Getting tattoos may help treat sclerosis- Research
A new study claims that getting a temporary tattoo containing antioxidant nano particles may help treat autoimmune diseases such as […]
Say something
A new study claims that getting a temporary tattoo containing antioxidant nano particles may help treat autoimmune diseases such as […]
Researchers are close to developing a blood test that can accurately detect the presence of Alzheimer’s disease at an early […]
Indian medical innovation has come to the forefront with the Human Embryonic Stem Cell technology developed by Dr Geeta Shroff […]
Siemens Healthcare has launched Magnetom Terra 7Tesla MRI system. The system is designed to translate cutting-edge MRI research results into […]
Drinking alcohol appears to have a dose-dependent inverse (opposite) association with the risk of developing multiple sclerosis (MS) and researchers […]
Research has become relatively easy today with open source data analysis software, image analysis software and websites. Dr Harsh Mahajan, […]
Ensure that laboratories are providing accurate testing results in vitamin D testing methodology. Dr JS Suri, Director-Dr Suri Lab When […]
Diagnosis of life-threatening diseases such as cancer may become a matter of minutes as scientists have developed a new bio-sensor technology, which they claim provides results within 15 minutes.
Up to 1 billion people, nearly one in six of the world’s population, suffer from neurological disorders, according to a new World Health Organisation (WHO) study titled “Neurological Disorders: Public health challenges”.
Thousands of patients suffering from Multiple Sclerosis in Canada and USA looking for CCSVI Screening availability who are unable find it due to long waiting period, high cost and cumbersome paper work are now looking at centres/hospitals in India.
The FDA has approved the drug, Ampyra (generic name dalfampridine, formerly known as fampridine), which is the first Multiple Sclerosis therapy that is taken orally and the first of its kind to receive FDA approval.
A Pennsylvania-based company has just released a healthcare management application that targets multiple sclerosis patients to the App Store.
Incepted in 2004, LifeCell International is India’s largest stem cell solutions provider involved in research, therapy, banking and clinical applications.